Skip to main content
CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
57.33
+0.73 (1.29%)
At close: Aug 13, 2025, 4:00 PM
59.15
+1.82 (3.17%)
Pre-market: Aug 14, 2025, 6:30 AM EDT

CRISPR Therapeutics AG Revenue by Segment
Period Ending Dec 31, 2024Dec 31, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Collaboration
405.00M 370.01M 170.10M 100.26M 436.00K 12.78M 13.01M 913.06M
Collaboration Growth
92,789.91% 2,795.65% 1,207.15% -89.02% -99.95% -98.58% -98.56% 155,181.80%
Grant
2.31M 3.01M - - - - - 2.31M - - - - - - - - - - - - - - -
Grant Growth
-23.22% - - - - - - - - - - - - - - - - - - - - - -

Operating Expense Breakdown
Period Ending Dec 31, 2024Dec 31, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019
Research and Development
320.65M 387.33M
Research and Development Growth
-17.22% -16.10%
Collaboration
- 130.25M 132.51M - - - - - - - - - -
Collaboration Growth
- 18.14% 11.49% - - - - - - - - - -
General and Administrative
72.98M 76.16M
General and Administrative Growth
-4.18% -25.67%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.